Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Australian Family Physician
|
July 29, 2000
Medial forefoot pain
P Baquie, R Morarty, M Blackney
Journal of Chromatography. A
|
April 21, 2015
A systematic approach for avoiding co-detection of oppositely charged analytes in dual-opposite-injection capillary electrophoresis
Donna M Blackney, Joe P Foley
Electrophoresis
|
November 19, 2016
Dual-opposite injection capillary electrophoresis: Principles and misconceptions
Donna M Blackney, Joe P Foley
Journal of Chromatography. A
|
September 3, 2017
Peak capacity and peak capacity per unit time in capillary and microchip zone electrophoresis
Joe P Foley, Donna M Blackney, Erin J Ennis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies
M Blackney, M Kelly, R Zeidman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Budget Impact of Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbohaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in the United Kingdom: Impact on Health Care Costs and Inhalation Technique
A Lewis, M Blackney, S Torvinen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in Sweden
A Lewis, M Blackney, S Torvinen, et al.
BMC Health Services Research
|
July 14, 2016
The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries
A Lewis, S Torvinen, P N R Dekhuijzen, et al.
Respiratory Medicine
|
July 23, 2017
Budesonide + formoterol delivered via Spiromax<sup>®</sup> for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler<sup>®</sup>
A Lewis, S Torvinen, P N R Dekhuijzen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Australian Family Physician
|
July 29, 2000
Medial forefoot pain
P Baquie, R Morarty, M Blackney
Journal of Chromatography. A
|
April 21, 2015
A systematic approach for avoiding co-detection of oppositely charged analytes in dual-opposite-injection capillary electrophoresis
Donna M Blackney, Joe P Foley
Electrophoresis
|
November 19, 2016
Dual-opposite injection capillary electrophoresis: Principles and misconceptions
Donna M Blackney, Joe P Foley
Journal of Chromatography. A
|
September 3, 2017
Peak capacity and peak capacity per unit time in capillary and microchip zone electrophoresis
Joe P Foley, Donna M Blackney, Erin J Ennis
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies
M Blackney, M Kelly, R Zeidman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Budget Impact of Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbohaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in the United Kingdom: Impact on Health Care Costs and Inhalation Technique
A Lewis, M Blackney, S Torvinen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in Sweden
A Lewis, M Blackney, S Torvinen, et al.
BMC Health Services Research
|
July 14, 2016
The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries
A Lewis, S Torvinen, P N R Dekhuijzen, et al.
Respiratory Medicine
|
July 23, 2017
Budesonide + formoterol delivered via Spiromax<sup>®</sup> for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler<sup>®</sup>
A Lewis, S Torvinen, P N R Dekhuijzen, et al.
Page
of 1